BLOG

Use of the recalled heartburn drug Zantac and generic ranitidine has been linked to an increased risk of cancer due to exposure to the carcinogenic substance N-nitrosodimethylamine (NDMA). Since Zantac (ranitidine) was introduced to the market in the early 1980s, millions of people have taken the drug to treat or prevent symptoms of heartburn, acid indigestion, gastroesophageal reflux disease (GERD), and ulcers of the stomach and intestines.

For more than 50 years, aqueous film-forming foam (AFFF), also known as firefighter foam or firefighting foam, has been used by civilian firefighters, on military bases, and at commercial airports to fight fuel-based fires on ships and aircraft and save human lives. Unfortunately, firefighters, military personnel, and veterans who used AFFF on the job may now be at risk for cancer and other potentially life-threatening side effects as a result of exposure to a group of toxic chemicals known as per- and polyfluoroalkyl substances (PFAS).

Uloric is a medication prescribed for the management of excess uric acid in the blood (hyperuricemia) of adult patients with gout. The number of medications available to treat gout is limited and for nearly ten years after it was approved by the FDA, Uloric was considered the gold standard for the treatment of the condition.

Type 2 diabetes and obesity are complex diseases that can substantially lower a person’s quality of life and decrease their life expectancy. Losing weight is an important health goal for individuals struggling with obesity, especially those diagnosed with type 2 diabetes, which is more common in overweight or obese people.

People who took the generic blood pressure drug valsartan may face an increased risk of certain cancers due to possible exposure to the carcinogenic chemical N-nitrosodimethylamine (NDMA), the same chemical that led to the high-profile removal of all Zantac and ranitidine products from the market in 2020. The companies that made and distributed valsartan pills contaminated with toxic NDMA are now facing a growing number of product liability lawsuits filed by former valsartan users who were diagnosed with cancer, which seek to hold the drug makers responsible for their tainted drug products.

People with type 2 diabetes generally have a higher risk of experiencing cardiovascular problems like heart attack and heart disease due to common diabetes-related complications like high cholesterol, obesity and high blood pressure. Diabetes drugs like Onglyza are often prescribed to type 2 diabetes patients to help keep their blood glucose levels under control, which can lower these cardiovascular risks.

Business owners across the country whose operations have been affected by the ongoing coronavirus pandemic and the associated quarantine efforts are pursuing business interruption lawsuits to recover the compensation they are entitled to for coronavirus-related business losses. The defendants in these lawsuits are insurers who are wrongfully denying legitimate claims from business owners who have paid their business interruption premiums for years and are now being denied essential coverage.

Hundreds of thousands of families across the United States have been affected by illnesses stemming from exposure to asbestos, which has been recognized as one of the largest man-made epidemics in our nation’s history and one that was completely preventable. As far back as the first century, exposure to asbestos was believed to trigger health problems and throughout the 20th century, medical professionals linked the carcinogen to a number of diseases.

Product liability lawsuits are being filed against the makers of Elmiron by consumers who claim that the prescription interstitial cystitis medication caused them to suffer retinal maculopathy and other eye diseases that may lead to permanent vision loss or blindness. A number of studies published over the last several years indicate that Elmiron, also known as pentosan polysulfate sodium or PPS, may be toxic to the retina, the thin layer of tissue at the back of the eye that senses light and allows us to see.

Leading talcum powder manufacturer Johnson & Johnson stopped selling its signature Baby Powder in 2020 following years of scrutiny surrounding the talc-based powder and its possible link to cancer. The issue with Johnson’s and other talcum powder products is the presence of talc, a very soft, naturally occurring mineral mined from the earth